The Role of Cathepsin D in the Pathophysiology of Heart Failure and its Potentially Beneficial Properties: A Translational Approach
Martijn F. Hoes(Maastricht University), Peter van der Meer(University Medical Center Groningen)
Cited by 39
Related Papers
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
|European Heart Journal|2022|1.1k
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
|New England Journal of Medicine|2024|356
The Clinical Significance of Interleukin-6 in Heart Failure: Results from the BIOSTAT-CHF Study
|European Journal of Heart Failure|2019|281
Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
|European Journal of Heart Failure|2024|64
Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease
|Nephrology Dialysis Transplantation|2025|18